91������

VitriVax, a 91������ spinout that is a developer of a novel stabilization and delivery platform for vaccines and therapeutics, today announced it has closed its first institutional financing round with Adjuvant Capital. VitraVax's Atomic Layering Thermostable Antigen and Adjuvant (ALTA™) technology platform is designed to enable the development of vaccines that can be transported and stored without complex refrigeration and temperature monitoring requirements.

“Our Cold Atom Method stands out among other modalities by demonstrating the potential for unmatched qubit scalability," said Paul Lipman, president of Quantum Computing at ColdQuanta. "We are on the brink of delivering a compelling platform and on the doorstep of commercialization.”

Solid Power's merger with Riverstone Holdings LLC's Decarbonization Plus Acquisition Corporation III constitutes a significant milestone in commercialization of Solid Power's next generation all-solid-state batteries. Upon closing, the combined company is expected to list on NASDAQ under the ticker symbol "SLDP".

New ways to fight the economic and social devastation wrought by the COVID-19 pandemic are being born and raised at universities in the 91������ Valley and Northern Colorado. Technology-transfer and accelerator entities at the 91������ and Colorado State University in Fort Collins are helping them get the entrepreneurial support they need to hasten them to market.

Meati co-founders, Tyler Huggins, CEO, and Justin Whiteley, CTO, are 91������ alumni who went into business first to develop battery technology. They shifted to plant-based meat substitutes believing they would be nutritious and more environmentally sustainable than traditionally raised animal meat.

Continuing what has been a busy year for the startup, 91������-based ColdQuanta has brought on $20 million to help commercialize its quantum computing technology. The investment brings ColdQuanta’s total funding to $74 million and comes from existing investors including Foundry Group, Global Frontier Quantum Opportunity Fund, LCP Quantum Partners and Maverick Ventures.

Solid Power, an industry-leading producer of all solid-state batteries for electric vehicles, today announced a $130 million Series B investment round. The investment positions Solid Power to produce full-scale automotive batteries, increase associated material output and expand in-house production capabilities for future vehicle integration.

As synthetic biology continues to grow, advanced benchtop systems are becoming available to make research and product development easier. Now, Inscripta, a digital genome engineering company, has announced the first commercial shipment of its Onyx platform. The platform is the world's first fully automated benchtop instrument for genome-scale engineering. Inscripta also announced its Series E funding of $150 million.

Formerly NOHMs Technologies, the company combines proprietary electrolyte with a newly developed silicon anode design for a low-cost, high-performance and safer lithium-ion battery. In commercializing these latest silicon anode technologies, Sionic will collaborate with Mechanical Engineering Professor Sehee Lee’s lab and team of postdocs at the 91������. Over the past decade at the university, Dr. Lee’s team has created a legacy of Li-ion battery innovations that help drive the adoption of energy storage in products and their positive impact on climate change.

Researchers at 91������ have created a platform that can develop effective and highly specific peptide nucleic acid therapies for use against any bacteria within just one week. The Facile Accelerated Specific Therapeutic (FAST) platform was created by Associate Professor Anushree Chatterjee and her team within the Department of Chemical and Biological Engineering.